Supplemental Figure 2 from Disruption of Autophagic Degradation with ROC-325 Antagonizes Renal Cell Carcinoma Pathogenesis
Jennifer S. Carew(University of Arizona), Steffan T. Nawrocki(University of Arizona), Valeria Visconte(Cleveland Clinic), Yingchun Han(Shenyang Agricultural University), William Zhao, James G. Phillips(Auckland University of Technology), Claudia M. Espitia(The University of Texas System)
Cited by 0
Related Papers
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
|Cancer Letters|2008|426
Bortezomib Inhibits PKR-Like Endoplasmic Reticulum (ER) Kinase and Induces Apoptosis via ER Stress in Human Pancreatic Cancer Cells
|Cancer Research|2005|324
Targeting HSP90 for cancer therapy
|British Journal of Cancer|2009|320